Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
about
Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous bodyOral antibiotic therapy for the treatment of infective endocarditis: a systematic reviewResistance pattern of ciprofloxacin against different pathogens.Animal models of bacterial keratitis.Topical ocular delivery of fluoroquinolones.Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis.Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant StaphylEfficacy of Caltropis procera and Ficus sycomorus extracts in treating MRSA (methicillin-resistant Staphylococcus aureus)-keratitis in rabbitEffect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis.Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.About the effect of eye blinking on drug release from pHEMA-based hydrogels: an in vitro study.Comparison of two hydrogel formulations for drug release in ophthalmic lenses.
P2860
Q34139885-636520F5-834A-448C-87A3-02CCF3B73C49Q35119494-D25BC5AB-24BF-4814-BC72-8BC8745CBE6CQ35323705-81EA93EA-727B-4339-A16B-17668BFB8F3DQ37832951-4DF2A10D-EFCC-4561-8879-07DE7FA7F319Q38082538-F2F245E8-33C1-4621-8DE5-5C1B23272449Q39663062-B84EDD76-DE4B-46D4-AA61-3819A4B5C86BQ41338294-A44E0B24-A6A1-4CCB-AED7-61B73A4736B2Q41844610-797C1EF3-95D2-4BEF-8494-D3AFF1A12BB7Q41990178-FD2EE260-4798-44BE-8B9B-5FFD202609DDQ42082902-E18F4A62-4DD1-4463-81B5-1F4785EB93D7Q42131745-BDF918F1-F297-4D41-B1B2-8950D2C24D0AQ42548959-DC022E25-1B89-43A8-94B9-C2A6D19E1474Q43025529-B04DCAC0-2225-4201-9652-DB1A8CD228B9Q44907582-EAF2C7C7-7B86-4450-AF1B-5FE39BA27527Q46899910-DF42407F-0402-469A-B4B5-09BB4503BC7EQ50986146-A085B9DC-0A3B-4731-A333-E55D2A750EECQ51124766-7732BFB0-9B00-4C00-9E35-DE77EA970DB7
P2860
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Effectiveness of ciprofloxacin ...... aphylococcus aureus keratitis.
@en
type
label
Effectiveness of ciprofloxacin ...... aphylococcus aureus keratitis.
@en
prefLabel
Effectiveness of ciprofloxacin ...... aphylococcus aureus keratitis.
@en
P2093
P2860
P1476
Effectiveness of ciprofloxacin ...... aphylococcus aureus keratitis.
@en
P2093
Brett A Thibodeaux
Dalia O Girgis
Joseph J Dajcs
Mary E Marquart
Mullika Traidej
Richard J O'Callaghan
P2860
P304
P356
10.1128/AAC.48.6.1948-1952.2004
P407
P577
2004-06-01T00:00:00Z